Global NGS-based RNA Sequencing Market – Size, Outlook, Trends and Forecast (2024 – 2032)

NGS-based RNA sequencing is next generation sequencing a DNA technology that has revolutionized genomic research which is used to identify giga base pairs of DNA sequence within a week which has drawn huge attention from the scientific research community. Global NGS-based RNA sequencing market value is projected to be $1.05 Billion in 2017 and is expected to generate revenue of around $3.80 Billion by the end of 2024, growing at a CAGR of around 20.20% between 2017 and 2024. Increasing number of RNA-sequence grants and advantages of RNA-sequence over microarray technology are the factors enhancing the growth of the market. Standardization concerns of RNA-sequencing in diagnostic testing and storage & interpretation of sequencing data are the factors which hamper the market growth.  Increasing applications of RNA-sequence in research and demand for cancer research centres are the opportunities for NGS-based RNA sequencing market.

Research Study Objectives:

• Define, estimate, and forecast the NGS-based RNA sequencing market statistics by technology, products and services, application end user and regions concerning the individual growth drivers, market trends and their contribution toward the NGS-based RNA sequencing market growth
• Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
• Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific, South America and the Middle East and Africa (MEA).
• Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the NGS-based RNA sequencing market analysis report.
• Analysis and conclusions on the future NGS-based RNA sequencing market outlook.

Top-down and bottom-up approaches are used to validate the NGS-based RNA sequencing market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The NGS-based RNA sequencing market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the NGS-based RNA sequencing market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The NGS-based RNA sequencing market segmentation is as follows:

By Technology

• Nano pore sequencing
• Single-molecule real-time sequencing
• Sequencing by synthesis
• Ion semiconductor sequencing

By Application

• Expression profiling analysis
• Small RNA sequencing
• De novo transcriptome assembly
• Variant calling and transcriptome epigenetics

By End User

• Research centers and academic & government institutes
• Hospitals & clinics
• Pharmaceutical & biotechnology companies
• Other end users

Geographical Analysis:

NGS-based RNA sequencing market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. The Asia Pacific is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the NGS-based RNA sequencing market include:

• Scope Revision
• Geographic Analysis
• Company Profiles
• Historical Data & Forecasting
• Key Contact Persons in companies

Global NGS-based RNA sequencing Market Research Report Includes:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
• Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact on altering market dynamics.
• Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Identify the latest developments, market shares and strategies that are employed by the significant NGS-based RNA sequencing market players, such as
  • GATC Biotech.
  • Eurofins Scientific
  • PerkinElmer, Inc.
  • Agilent Technologies, Inc.
  • Hoffmann-La Roche AG.
• Along with these companies, many other companies are considered in the report while analysing the global NGS-based RNA sequencing competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.